Sign in

You're signed outSign in or to get full access.

NeueHealth (NEUE)

--

Earnings summaries and quarterly performance for NeueHealth.

Research analysts covering NeueHealth.

Recent press releases and 8-K filings for NEUE.

NeueHealth Announces Q2 2025 Financial Results
NEUE
Earnings
M&A
  • NeueHealth reported strong financial results for the second quarter ended June 30, 2025, achieving its sixth consecutive quarter of positive Adjusted EBITDA. Adjusted EBITDA for Q2 2025 was $19.02 million, significantly up from $3.96 million in Q2 2024.
  • The company recorded net income from continuing operations of $6.84 million in Q2 2025, a substantial improvement from a net loss of $(39.26) million in Q2 2024.
  • Consumer engagement grew significantly, with approximately 694,000 consumers served in Q2 2025, representing a 45% increase over Q2 2024.
  • The company is focused on advancing its value-based care enablement platform and reported strong performance across the ACA Marketplace, Medicare, and Medicaid product categories.
  • A pending merger transaction with NH Holdings 2025, Inc., indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. (NEA), was entered into on December 23, 2024.
Aug 7, 2025, 12:00 AM
NeueHealth Q1 2025 Financial & Merger Update
NEUE
M&A
Proxy Vote Outcomes
Earnings
Revenue Acceleration/Inflection
  • On May 7, 2025, NeueHealth held a special stockholders meeting approving the Merger Agreement to become a wholly owned subsidiary of its Parent, paving the way to go private (, , ).
  • Q1 2025 highlights: Achieved $215.8M revenue, $13.5M adjusted EBITDA (fifth consecutive profitable quarter) and an improved 25.4% gross margin (, , ).
  • Strategic update: Announced the move to go private (expected to close by mid-2025) and emphasized a consumer-centric care model resonating with providers and payors (, , ).
  • Expanded its consumer base to 709,000, marking a 51% YoY increase (, , ).
  • Segment performance: New Care delivered $90.5M in revenue with $23M operating income, while New Solutions generated $127.6M in revenue with a $3M operating loss ().
  • Maintained a robust balance sheet with $239.4M in total cash and investments ().
May 8, 2025, 12:00 AM
NeueHealth Reports Q4 2024 Earnings and Acquisition Agreement
NEUE
Earnings
M&A
  • Robust financial performance: Q4 consolidated revenue was $232.6M and full-year revenue reached $936.7M with corresponding adjusted EBITDA of $5.5M in Q4 and $22.5M for the year, marking the strongest financial performance to date.
  • Significant consumer growth: The company served 483,000 consumers in 2024 and has already expanded to 717,000 consumers in early 2025, demonstrating strong growth in its core segments .
  • Strategic acquisition move: A definitive agreement to be acquired by an affiliate of NEA was announced, with the transaction expected to close in Q2 2025, transitioning NeueHealth to a privately held company.
Mar 20, 2025, 12:01 PM
NeueHealth Inc Reports Q4 2024 Results
NEUE
Earnings
Revenue Acceleration/Inflection
  • Q4 revenue of $232.6M was in line with expectations, with an improved gross margin of 20.5% for continuing operations.
  • The quarter achieved an adjusted EBITDA of $5.5M, marking the fourth consecutive quarter of adjusted EBITDA profitability.
  • Strong full year 2024 performance was highlighted by $936.7M in revenue and $22.5M in adjusted EBITDA, underscoring a solid turnaround.
Mar 20, 2025, 12:00 PM
NeueHealth Posts Strong Q4 2024 Results
NEUE
Earnings
Revenue Acceleration/Inflection
  • Delivered its strongest financial performance to date in 2024, driven by a consumer-centric care model, and set the stage for continued growth in 2025.
  • Achieved positive Adjusted EBITDA for the fourth consecutive quarter, highlighting improved operational efficiency.
  • Key consumer metrics improved, with 360,000 value-based consumers served in 2024 versus 355,000 in 2023, and 123,000 enablement services lives compared to 106,000 in 2023.
  • Reported significant growth for early 2025, serving 717,000 consumers, marking a 48% increase over 2024.
Mar 20, 2025, 12:00 AM
NeueHealth, Inc. Modifies CMS Repayment Terms and Announces Merger Agreement
NEUE
M&A
  • CMS Agreement Modification: The Company’s insurance subsidiaries in Colorado and Florida executed Letters of Agreement with CMS to modify the repayment terms for an outstanding $271.8 million risk adjustment obligation, now due in 36 months and accruing interest at 11.5% per annum with additional payment conditions, including monthly payments of $1,000.
  • Merger Announcement: The Company entered into a Merger Agreement with NH Holdings 2025, Inc. to become a wholly owned subsidiary of Parent, indirectly controlled by NEA, with detailed disclosures and related filings forthcoming.
Mar 19, 2025, 12:00 AM